Medtronic Faces $88 Million Verdict in Hernia Mesh Trial

Medtronic has been ordered to pay $88 million in a verdict related to a hernia mesh trial. The jury found that the company was liable for damages due to complications linked to its product. This verdict comes amidst ongoing litigation concerning the safety and effectiveness of Medtronic's hernia mesh devices. Such legal outcomes can impact Medtronic's (MDT) reputation and financial performance, influencing investor sentiment and market confidence.